Another drug firm faces potential fines for research non-reporting

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesClinical TrialsComplianceEthicsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy